Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.350
-0.010 (-0.30%)
Oct 7, 2025, 12:45 PM EDT - Market open
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $1.95 million as of October 7, 2025. Its market cap has decreased by -8.36% in one year.
Market Cap
1.95M
Enterprise Value
-4.18M
1-Year Change
-8.36%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $1.95M, a decrease of -99.40%. That is a compound annual growth rate of -73.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 1.96M | -79.02% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
| Dec 10, 2021 | 323.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |